Facebook
Twitter
LinkedIn
Forward
On-Demand: Perinatal Psychiatry: In-Depth Modules for Enhanced Approaches
This course will focus on the diagnosis and treatment of psychiatric disorders in women across pregnancy and the postpartum. Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy, pregnancy planning, and the postpartum. Exposure to psychotropic medications and the consequence of untreated psychiatric disorders must be considered when treating pregnant women, those who may become pregnant during treatment, and those who are breastfeeding. Up to date and comprehensive knowledge is required to help patients make collaborative and individualized treatment decisions. A strong understanding of the literature pertaining to the reproductive safety of medications is imperative to factoring in potential risks and benefits of medication, and context is particularly critical in putting risks into perspective. Focused material will also be presented regarding specialized psychotherapies utilized during pregnancy and the postpartum, as well as an overview of embryology and obstetrics informing a broad range of care modalities. Learning in this course will be facilitated by didactic materials delivered by the faculty from the MGH Center for Women’s Mental Health. Faculty will also provide question and answer and case-based discussion sessions for course participants. Readings to accompany course materials will also be provided.
Pricing per Module
Physicians and Doctoral-level Professionals: $95.00
Other Professionals: $75.00
Restriction on Use of Materials
This site is operated and maintained by The Massachusetts General Hospital Psychiatry Academy. No material or information from this site may be copied, reproduced, republished, uploaded, posted, transmitted or distributed unless approved in writing by The Psychiatry Academy. Questions concerning the proper use of materials and information in this site should be directed to: mghcme@mgh.harvard.edu. No rights or licenses of any kind of The Psychiatry Academy’s intellectual property are transferred to, granted to, provided to or received by you as a result of using this web site.
Cancellation Policy
A $10.00 administrative fee will be applied.
Target Audience
This program is intended for: Practicing psychiatrists, primary care physicians, and nurse practitioners.
Learning Objectives
Psychiatric Disorders During Pregnancy
- Discuss critical research findings in reproductive psychiatry that inform clinical care
- Describe the current knowledge gaps in reproductive psychopharmacology over the last decade
- Explain current treatment algorithms for screening and treatment of psychiatric disorders during pregnancy
Postpartum Mood and Anxiety Disorders
- Describe and apply the risks/benefits safety of psychiatric medication during the postpartum and breastfeeding context
- Identify strategies for screening and treatment of postpartum depression
- Define the presentation and treatment of postpartum psychosis; and describe and assess the vulnerability for mood episodes in women with bipolar disorder and acute treatment and preventative strategies
Sorting Through the Data: Where do patients and providers go for information?
- Identify reliable resources for information on the reproductive safety of medications
- Discuss the strengths and limitations of the Pregnancy and Lactation Labeling Rule (PLLR)
- Use basic tools for the evaluation of reproductive safety data in the medical literature
Substance Use Disorders in Pregnancy and the Postpartum
- Discuss the pharmacologic treatments of substance us disorders in pregnant and postpartum women
- Explain the importance of screening, assessment and treatment of comorbid psychiatric conditions in women with SUD
- Describe the psychosocial and environmental factors in the practice of “low barrier psychiatry” for pregnant and postpartum women with substance use disorders
Specialized Psychotherapies for Pregnancy and Postpartum
- Discuss the types and value of psychotherapy in consideration of perinatal mental health
- Describe the research on evidence-based psychotherapy for perinatal mental health
- Identify common barriers to psychotherapy and novel strategies to address the gaps in perinatal mental health treatments
Medication Teratogenesis and Pregnancy Complications
- Identify the timing and impact of medication exposures on fetal development
- Describe the knowledge gaps in our understanding of medication safety
- Demonstrate a general understanding of common obstetrical complications
Topic | Speaker |
Psychiatric Disorders During Pregnancy | Lee Cohen, MD |
Postpartum Mood and Anxiety Disorders | Marlene Freeman, MD |
Sorting Through the Data: Where do patients and providers go for information? | Ruta Nonacs, MD, PhD |
Substance Use Disorders in Pregnancy and the Postpartum | Edwin Raffi, MD, MPH |
Specialized Psychotherapies for Pregnancy and Postpartum | Rachel Vanderkruik, PhD |
| Medication Teratogenesis and Pregnancy Complications | Sarah Bernstein, MD |
Available Credit
- 5.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Enduring activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 5.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 5.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 5.00 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 5.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D90156
- 5.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 5.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 5.00 Continuing Education (CE) credits per presentation for psychologists.
Price
Release Date: January 23, 2021
Expiration Date: February 9, 2025
Review Date: January 23, 2022 by Robert Althoff, MD, PhD
Course Director(s)
Lee Cohen, MD
Marlene Freeman, MD
Planners
David H. Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer, moderator
Lee Cohen, MD
Marlene Freeman, MD
ARCHIVED DISCLOSURES
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:
Commercial Interest
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org.
Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Relevant financial relationships
ACCME focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of this activity) consumed by, or used on, patients:
Susan Sprich, PhD
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:
Ineligible Companies
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit
Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education.
Marlene P. Freeman, MD
Investigator Initiated Trials (Research): JayMac, Sage
Advisory Board: Otsuka, Alkermes, Sunovion Pharmaceuticals
Independent Data Safety and Monitoring Committee (Honoraria): Janssen (Johnson& Johnson)
Dr. Freeman is an employee of Massachusetts General Hospital, and works with the MGH National Pregnancy Registry [Current Registry Sponsors]: Teva, Alkermes, Inc., Otsuka America Pharmaceutical, Inc., Forest/Actavis, Sunovion Pharmaceuticals, Inc.
Steering Committee for Educational Activities: Medscape
Lee S. Cohen, PhD
Research Support: National Pregnancy Registry for Psychiatric medications, Alkermes Biopharmaceuticals ; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals, Inc; Supernus Pharmaceuticals
Other Research Support: Brain & Behavior Research Foundation; JayMac Pharmaceuticals; National Institute on Aging; National Institutes of Health; SAGE Therapeutics
Advisory/Consulting (through MGH Clinical Trials Network Initiative): Alkermes Biopharmaceuticals; Praxis Precision Medicines, Inc.
All other individuals in a position to control the content of this educational activity have reported no financial relationships with ineligible companies.
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
Privacy Policy
Please click here to review our privacy policy.